Home Great Bay Bio to Showcase AI-Powered Antibody Engineering Platform at Antibody Engineering & Therapeutics 2025 in San Diego

Great Bay Bio to Showcase AI-Powered Antibody Engineering Platform at Antibody Engineering & Therapeutics 2025 in San Diego

Dec 11, 2025 09:00 CST Updated 09:00
GBB

AI Biomedical R&D Company

Image


The world's top conference on antibody engineering, Antibody Engineering & Therapeutics (AET), will be held in San Diego, USA, from December 14 to 17, 2025.GBB invites you to this industry盛会 to explore innovative solutions of intelligent technology platforms for empowering antibody engineering development, helping customers develop products faster and better.


Antibody Engineering & Therapeutics 2025.jpg



This exhibition brings together 900+ antibody scientists and industry executives, 75+ leading exhibitors, 135+ cutting-edge technology speeches, and 125+ breakthrough research posters, focusing on the application of new technologies such as artificial intelligence and computing power breakthroughs.Empower attendees to master cutting-edge antibody engineering technologies that can be directly applied to R&D projects, accelerating the development and commercialization of next-generation drugs such as antibodies, proteins, bispecific antibodies, multi-specific antibodies, and ADCs.



GBB Team to Showcase Practical Intelligent Technology Platform at This Conference (Booth No.: 512), Offering Innovative Solutions for Antibody Engineering Drug Development. This platform integrates cutting-edge technologies such as AI, automation, and big data analysis.Completed the process from target/antibody drug discovery to early CMC work in 8 months, significantly shortening the traditional R&D cycle, bringing revolutionary changes to antibody drug development.


大湾生物展位.png



About AET 2025



AET 2025 brings together over 900 antibody scientists and industry executives globally, 75+ leading exhibitors, 135+ cutting-edge technology presentations, and 125+ breakthrough research posters. Focusing on the application of new technologies such as artificial intelligence and computing power breakthroughs, it helps participants master the latest antibody engineering technologies that can be directly applied to R&D projects, accelerating the development and commercialization of next-generation drugs like antibodies, proteins, bispecific antibodies, multispecific antibodies, and ADCs.



赞助单位.png




Schedule Business Consultation


Email: BD@greatbay-bio.com


Phone: 18926497707 (Same for WeChat)


Image




Image